StockData
InspireMD, Inc. logo

InspireMD, Inc. (NSPR) stock

NSPRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/3050% below fair value
$0.62−0.07 (-9.50%)

Close on Nov 19, 2026Market cap $28.85MP/E –Yield –

InspireMD gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

InspireMD's gross profit for the twelve months ending Jun 30, 2026 was $1.96M, up 31.5% year over year. For fiscal 2025 it was $2.65M, up 75.9% from the year before. The highest annual figure on record is $2.65M in fiscal 2025.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.65M+75.9%
FY2024Dec 31, 2024$1.51M-16.7%
FY2023Dec 31, 2023$1.81M+61.8%
FY2022Dec 31, 2022$1.12M+48.1%
FY2021Dec 31, 2021$754.00K+808.4%
FY2020Dec 31, 2020$83.00K-89.0%
FY2019Dec 31, 2019$756.00K-24.0%
FY2018Dec 31, 2018$995.00K+70.1%
FY2017Dec 31, 2017$585.00K+473.5%
FY2016Dec 31, 2016$102.00K–
FY2015Dec 31, 2015-$296.00K-111.4%
FY2013Jun 30, 2013$2.59M+15.0%
FY2010Dec 31, 2010$2.25M+101.2%
FY2009Dec 31, 2009$1.12M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$774.00K-347.3%
Q1 FY2026Mar 31, 2026$687.00K+135.3%
Q4 FY2025Dec 31, 2025$1.18M+151.6%
Q3 FY2025Sep 30, 2025$864.00K+108.7%
Q2 FY2025Jun 30, 2025$313.00K-5.4%
Q1 FY2025Mar 31, 2025$292.00K0.0%
Q4 FY2024Dec 31, 2024$469.00K-7.1%
Q3 FY2024Sep 30, 2024$414.00K-5.5%
Q2 FY2024Jun 30, 2024$331.00K-32.6%
Q1 FY2024Mar 31, 2024$292.00K-21.7%
Q4 FY2023Dec 31, 2023$505.00K+155.1%
Q3 FY2023Sep 30, 2023$438.00K+19.7%
Q2 FY2023Jun 30, 2023$491.00K+13.9%
Q1 FY2023Mar 31, 2023$373.00K+205.7%
Q4 FY2022Dec 31, 2022$198.00K-32.7%
Q3 FY2022Sep 30, 2022$366.00K+297.8%
Q2 FY2022Jun 30, 2022$431.00K+64.5%
Q1 FY2022Mar 31, 2022$122.00K+15.1%
Q4 FY2021Dec 31, 2021$294.00K–
Q3 FY2021Sep 30, 2021$92.00K-69.1%
Q2 FY2021Jun 30, 2021$262.00K–
Q1 FY2021Mar 31, 2021$106.00K-64.1%
Q4 FY2020Dec 31, 2020-$390.00K-250.6%
Q3 FY2020Sep 30, 2020$298.00K+132.8%
Q2 FY2020Jun 30, 2020-$120.00K-127.1%
Q1 FY2020Mar 31, 2020$295.00K–
Q4 FY2019Dec 31, 2019$259.00K+14.1%
Q3 FY2019Sep 30, 2019$128.00K-35.4%
Q2 FY2019Jun 30, 2019$442.00K+59.6%
Q1 FY2019Mar 31, 2019-$73.00K-124.9%
Q4 FY2018Dec 31, 2018$227.00K+7.6%
Q3 FY2018Sep 30, 2018$198.00K+29.4%
Q2 FY2018Jun 30, 2018$277.00K+88.4%
Q1 FY2018Mar 31, 2018$293.00K+295.9%
Q4 FY2017Dec 31, 2017$211.00K–
Q3 FY2017Sep 30, 2017$153.00K+410.0%
Q2 FY2017Jun 30, 2017$147.00K–
Q1 FY2017Mar 31, 2017$74.00K–
Q4 FY2016Dec 31, 2016-$56.00K–
Q3 FY2016Sep 30, 2016$30.00K–

More InspireMD figures

See a number that looks wrong?